von Willebrand factor D'D3 domain (VWF D'D3)

The von Willebrand factor (VWF) D'D3 domain is a specialized structural region of the VWF glycoprotein that is essential for the stabilization and transport of coagulation Factor VIII (FVIII) in the blood (UniProt P04275). By binding FVIII with high affinity, the D'D3 domain shields it from premature clearance and proteolytic inactivation by activated protein C, effectively extending the half-life of FVIII from minutes to approximately 15 hours (Lenting et al., 2015). Genetic mutations within this domain can lead to von Willebrand disease (VWD) Type 2N, where the inability of VWF to bind FVIII results in low FVIII levels, mimicking Hemophilia A (Lillicrap, 2008). In therapeutic applications, the D'D3 domain has become a target for protein engineering; for instance, Efanesoctocog alfa incorporates a VWF D'D3 fragment to decouple FVIII from endogenous VWF, allowing for once-weekly dosing in Hemophilia A patients (Konkle et al., 2023). This domain is therefore a critical component in both the pathophysiology of bleeding disorders and the development of next-generation hematologic therapies.

Other names

D'D3 region of von Willebrand factorFactor VIII-binding domain of VWFVWF D'D3 assemblyD'D3 domain

Stabilization and protection of Factor VIII from premature clearance and proteolytic inactivation, thereby extending its circulatory half-life and maintaining hemostatic capacity.